Obesity Featured Articles
-
Why In The World Should You Come To San Diego?
4/19/2024
With over 180 sessions across 13 tracks and nine engaging learning formats, attendees will delve into emerging fields such as precision medicine, regulatory CMC, and product quality, and value-based access.
-
Reporting To The IRB: Investigator Noncompliance
4/19/2024
Reporting noncompliance concerns is crucial to protect research participants. By promptly reporting noncompliance, researchers can ensure ethical research conduct and protect the rights and welfare of participants.
-
Understanding FDA’s 2024 Draft Guidance On DMCs
4/19/2024
By integrating independent Data Monitoring Committees into trial management processes, learn how sponsors can enhance trust, integrity, and the success of their clinical trials.
-
The Value Of Continuity: Program-Level DSMBs
4/19/2024
Discover the strategic benefits of deploying consistent DSMB members across therapeutic programs, highlighting the pivotal role of program-level supervision in safeguarding the safety and effectiveness of novel treatments.
-
Considering The Patient Experience Is Critical To Creating A Successful ICF
4/19/2024
If an ICF is not written with the patient in mind — so that it truly facilitates an informed consent — a clinical trial runs the risk of losing viable study participants and derailing study start-up, even success.
-
When Quickbooks Leaves Your Life Sciences Venture Struggling
4/18/2024
Is QuickBooks keeping pace with your life sciences venture? Learn the signs it's time to move beyond and adopt tailored solutions for growth, compliance, collaboration, security, and automation.
-
$100M In Government Funding Helps, But What Can Really Be Done About Trial Diversity?
4/18/2024
Breast surgical oncologist and medical director Monique Gary, DO lists three steps to take right now to improve clinical trial patient diversity.
-
Diversity And Inclusion In Oncology Clinical Trials
4/17/2024
Despite challenges, learn how sponsors can implement diversity plans to enroll and retain clinically relevant participants, including minorities, older patients, and those with disabilities.
-
Cell & Gene Therapies: An Overview Of FDA Regulatory Considerations For 2024
4/17/2024
This article outlines key FDA regulatory developments from the past few months relevant to sponsors seeking approval of cell and gene therapies in the U.S.
-
3 Steps For Internal Or Family Medicine Clinical Trials Enrollment
4/17/2024
If 25% of U.S. adults don’t have a primary care provider, how can you access enough patients to fill your internal or family medicine clinical trial? Here are 3 tips.